Lv53
950 积分 2025-08-18 加入
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
2天前
已完结
Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial
2天前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
1个月前
已完结
Quality of Life Benefit and Clinical Predictors of Complete Skin Clearance in Psoriasis: A Multicenter, Prospective, Real-World Study
5个月前
已完结
Incidence and Risk of Glucocorticoid‐Associated Adverse Effects in Patients With Rheumatoid Arthritis
5个月前
已完结
Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trials
5个月前
已完结
Chinese SLE Treatment and Research group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus
6个月前
已完结
Systemic Lupus Erythematosus
6个月前
已完结
Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets
6个月前
已完结
皖公网安备34019202002308
